Search research articles
Contact Us
Filters
Showing results (61-70 of 100) with videos related to
Page
of 10
Sort By:
Current Cancer Drug Targets
|
November 2, 2018
The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy
Mingxia Wu, Christy W S Tong, Wei Yan, et al.
Pharmaceutics
|
July 30, 2025
Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer
Hang Zhang, Longling Wang, Yuet Wa Chan, et al.
Seminars in Cancer Biology
|
May 13, 2025
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury
Kenneth K W To, Seda S Tolu, Longling Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 16, 2004
Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation
Yukio Kageyama, Minori Koshiji, Kenneth K W To, et al.
Bioorganic & Medicinal Chemistry
|
September 11, 2004
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin
Kenneth K W To, Xinning Wang, Chun Wing Yu, et al.
International Journal of Pharmaceutics
|
January 10, 2012
Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic
Bin Ma, Stella Chai, Na Li, et al.
Molecular Cell
|
March 23, 2005
HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression
Minori Koshiji, Kenneth K-W To, Stefanie Hammer, et al.
Expert Opinion on Drug Discovery
|
November 20, 2019
Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
Kenneth K W To, Winnie Fong, Christy W S Tong, et al.
Signal Transduction and Targeted Therapy
|
August 29, 2020
Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
Min Luo, Fang Wang, Hong Zhang, et al.
European Journal of Medicinal Chemistry
|
July 22, 2015
Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives
Xu-Qin Li, Lin Wang, Yan Lei, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 100) with videos related to
Sort By:
Page
of 10
Current Cancer Drug Targets
|
November 2, 2018
The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy
Mingxia Wu, Christy W S Tong, Wei Yan, et al.
Pharmaceutics
|
July 30, 2025
Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer
Hang Zhang, Longling Wang, Yuet Wa Chan, et al.
Seminars in Cancer Biology
|
May 13, 2025
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury
Kenneth K W To, Seda S Tolu, Longling Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 16, 2004
Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation
Yukio Kageyama, Minori Koshiji, Kenneth K W To, et al.
Bioorganic & Medicinal Chemistry
|
September 11, 2004
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin
Kenneth K W To, Xinning Wang, Chun Wing Yu, et al.
International Journal of Pharmaceutics
|
January 10, 2012
Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic
Bin Ma, Stella Chai, Na Li, et al.
Molecular Cell
|
March 23, 2005
HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression
Minori Koshiji, Kenneth K-W To, Stefanie Hammer, et al.
Expert Opinion on Drug Discovery
|
November 20, 2019
Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
Kenneth K W To, Winnie Fong, Christy W S Tong, et al.
Signal Transduction and Targeted Therapy
|
August 29, 2020
Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
Min Luo, Fang Wang, Hong Zhang, et al.
European Journal of Medicinal Chemistry
|
July 22, 2015
Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives
Xu-Qin Li, Lin Wang, Yan Lei, et al.
Page
of 10